SciBase Holding AB (publ)
STO:SCIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SciBase Holding AB (publ)
Free Cash Flow
SciBase Holding AB (publ)
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SciBase Holding AB (publ)
STO:SCIB
|
Free Cash Flow
-kr84.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-6%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Free Cash Flow
kr1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Free Cash Flow
kr114.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
4%
|
|
|
Getinge AB
STO:GETI B
|
Free Cash Flow
kr3.3B
|
CAGR 3-Years
44%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Free Cash Flow
kr1B
|
CAGR 3-Years
56%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Free Cash Flow
kr15.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
SciBase Holding AB (publ)
Glance View
SciBase Holding AB is a global medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases. The company is headquartered in Sundbyberg, Stockholm and currently employs 23 full-time employees. The company went IPO on 2015-06-02. The firm specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.
See Also
What is SciBase Holding AB (publ)'s Free Cash Flow?
Free Cash Flow
-84.8m
SEK
Based on the financial report for Dec 31, 2025, SciBase Holding AB (publ)'s Free Cash Flow amounts to -84.8m SEK.
What is SciBase Holding AB (publ)'s Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-6%
Over the last year, the Free Cash Flow growth was -47%. The average annual Free Cash Flow growth rates for SciBase Holding AB (publ) have been -24% over the past three years , -20% over the past five years , and -6% over the past ten years .
